Eikon Therapeutics inks Series B

Eikon Therapeutics Inc, a California-based drug discovery and development company, has secured $517.8 million in Series B financing.

Eikon Therapeutics Inc, a California-based drug discovery and development company, has secured $517.8 million in Series B financing. The investors include T. Rowe Price Associates, Inc., Canada Pension Plan Investment Board, EcoR1 Capital and UC Investments.

Source: Press Release